FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

18290311000001104: Brilique 90mg tablets (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jan 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62647901000001113 Brilique 90mg tablets (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62648001000001110 Brilique 90mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brilique 90mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Is a Ticagrelor 90mg tablets false Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has specific active ingredient Ticagrelor false Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Is a Brilique true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has specific active ingredient Ticagrelor true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has active ingredient Ticagrelor false Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Is a Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Brilique 90mg tablets (AstraZeneca UK Ltd) 56 tablet 4 x 14 tablets Has AMP True Brilique 90mg tablets (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start